{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:00:53Z","timestamp":1780664453142,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82274034"],"award-info":[{"award-number":["82274034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47912-w","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:18:03Z","timestamp":1776179883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["5-hydroxymethylcytosine signatures of tissue as potential predictive markers for platinum resistance in epithelial ovarian cancer patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Yuan","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanmiao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanqun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"4","key":"47912_CR1","first-page":"284","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre, L. A. et al. Ovarian cancer statistics, 2018. CA Cancer J. Clin. 68(4), 284\u2013296 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"47912_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.23.01771","volume":"42","author":"J St Laurent","year":"2024","unstructured":"St Laurent, J. & Liu, J. F. Treatment approaches for platinum-resistant ovarian cancer. J. Clin. Oncol. 42(2), 127\u2013133 (2024).","journal-title":"J. Clin. Oncol."},{"key":"47912_CR3","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis, U. A. et al. Ovarian cancer. Nat. Rev. Dis. Primers 2, 16061 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"47912_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12916-017-0870-0","volume":"15","author":"T Tomar","year":"2017","unstructured":"Tomar, T. et al. Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer. BMC Med. 15(1), 116 (2017).","journal-title":"BMC Med."},{"issue":"6626","key":"47912_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1126\/science.abn4009","volume":"378","author":"SE Johnstone","year":"2022","unstructured":"Johnstone, S. E. et al. Epigenetic clocks, aging, and cancer. Science 378(6626), 1276\u20131277 (2022).","journal-title":"Science"},{"issue":"9","key":"47912_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrg.2017.33","volume":"18","author":"X Wu","year":"2017","unstructured":"Wu, X. & Zhang, Y. TET-mediated active DNA demethylation: Mechanism, function and beyond. Nat. Rev. Genet. 18(9), 517\u2013534 (2017).","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"47912_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202300747","volume":"8","author":"Y Ren","year":"2024","unstructured":"Ren, Y. et al. A highly sensitive and specific non-invasive test through genome-wide 5-Hydroxymethylation mapping for early detection of lung cancer. Small Methods 8(3), e2300747 (2024).","journal-title":"Small Methods"},{"issue":"1","key":"47912_CR8","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1038\/s41467-020-20001-w","volume":"11","author":"XL Cui","year":"2020","unstructured":"Cui, X. L. et al. A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation. Nat. Commun. 11(1), 6161 (2020).","journal-title":"Nat. Commun."},{"issue":"1","key":"47912_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24425-w","volume":"12","author":"B He","year":"2021","unstructured":"He, B. et al. Tissue-specific 5-hydroxymethylcytosine landscape of the human genome. Nat. Commun. 12(1), 4249 (2021).","journal-title":"Nat. Commun."},{"issue":"1","key":"47912_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.30146","volume":"69","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine contents are decreased in the early stage of hepatocellular carcinoma. Hepatology 69(1), 196\u2013208 (2019).","journal-title":"Hepatology"},{"issue":"12","key":"47912_CR11","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1136\/gutjnl-2019-318882","volume":"68","author":"J Cai","year":"2019","unstructured":"Cai, J. et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut 68(12), 2195\u20132205 (2019).","journal-title":"Gut"},{"issue":"4","key":"47912_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","volume":"5","author":"H Zheng","year":"2024","unstructured":"Zheng, H. et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat. Cancer 5(4), 572\u2013589 (2024).","journal-title":"Nat. Cancer"},{"key":"47912_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ygyno.2024.01.001","volume":"182","author":"M Weigert","year":"2024","unstructured":"Weigert, M. et al. 5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer. Gynecol. Oncol. 182, 82\u201390 (2024).","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"47912_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nbt.1732","volume":"29","author":"CX Song","year":"2011","unstructured":"Song, C. X. et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 29(1), 68\u201372 (2011).","journal-title":"Nat. Biotechnol."},{"key":"47912_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.781267","volume":"9","author":"HY Chen","year":"2021","unstructured":"Chen, H. Y. et al. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as early warning biomarkers for COVID-19 progression and myocardial injury. Front. Cell Dev. Biol. 9, 781267 (2021).","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"47912_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9(4), 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"issue":"9","key":"47912_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9(9), R137 (2008).","journal-title":"Genome Biol."},{"issue":"6","key":"47912_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics 26(6), 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"issue":"3","key":"47912_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen, W. et al. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta 1(3), e36 (2022).","journal-title":"iMeta"},{"issue":"1","key":"47912_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"47912_CR21","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M. et al. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45(D1), D353-d361 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"47912_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672-d677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"47912_CR23","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"3","key":"47912_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00441-014-1896-7","volume":"356","author":"GP Pfeifer","year":"2014","unstructured":"Pfeifer, G. P. et al. The role of 5-hydroxymethylcytosine in human cancer. Cell Tissue Res. 356(3), 631\u2013641 (2014).","journal-title":"Cell Tissue Res."},{"issue":"5","key":"47912_CR25","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1039\/D3CS00858D","volume":"53","author":"E Kriukien\u0117","year":"2024","unstructured":"Kriukien\u0117, E., Tomkuvien\u0117, M. & Klima\u0161auskas, S. 5-Hydroxymethylcytosine: The many faces of the sixth base of mammalian DNA. Chem. Soc. Rev. 53(5), 2264\u20132283 (2024).","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"47912_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-022-05406-3","volume":"14","author":"XJ Guo","year":"2023","unstructured":"Guo, X. J. et al. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC\/PCAF\/AKT axis. Cell Death Dis. 14(2), 79 (2023).","journal-title":"Cell Death Dis."},{"issue":"1","key":"47912_CR27","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan, Y. et al. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat. Commun. 13(1), 4554 (2022).","journal-title":"Nat. Commun."},{"issue":"10","key":"47912_CR28","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/s00432-020-03317-4","volume":"146","author":"T Kaltofen","year":"2020","unstructured":"Kaltofen, T. et al. Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer. J. Cancer Res. Clin. Oncol. 146(10), 2559\u20132574 (2020).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"47912_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","volume":"24","author":"H Li","year":"2022","unstructured":"Li, H. et al. YAP\/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis. Nat. Cell Biol. 24(3), 373\u2013383 (2022).","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"47912_CR30","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1158\/1078-0432.CCR-18-2554","volume":"25","author":"G Wu","year":"2019","unstructured":"Wu, G. et al. Loss of RBMS3 confers platinum resistance in epithelial ovarian cancer via activation of miR-126-5p\/\u03b2-catenin\/CBP signaling. Clin. Cancer Res. 25(3), 1022\u20131035 (2019).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"47912_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14488","volume":"103","author":"X Li","year":"2024","unstructured":"Li, X. et al. Serum exosomal miR-3662 down-regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells. Chem. Biol. Drug Des. 103(3), e14488 (2024).","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"47912_CR32","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","volume":"9","author":"T Nechiporuk","year":"2019","unstructured":"Nechiporuk, T. et al. The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discov. 9(7), 910\u2013925 (2019).","journal-title":"Cancer Discov."},{"issue":"1","key":"47912_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-025-02345-3","volume":"24","author":"H Alizadeh","year":"2025","unstructured":"Alizadeh, H. et al. A comprehensive overview of ovarian cancer stem cells: Correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities. Mol. Cancer 24(1), 135 (2025).","journal-title":"Mol. Cancer"},{"issue":"5","key":"47912_CR34","first-page":"1980","volume":"53","author":"X Lei","year":"2018","unstructured":"Lei, X. et al. ARHGEF7 promotes metastasis of colorectal adenocarcinoma by regulating the motility of cancer cells. Int. J. Oncol. 53(5), 1980\u20131996 (2018).","journal-title":"Int. J. Oncol."},{"issue":"1","key":"47912_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3892\/or.2020.7594","volume":"44","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma. Oncol. Rep. 44(1), 55\u201368 (2020).","journal-title":"Oncol. Rep."},{"issue":"19","key":"47912_CR36","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1158\/0008-5472.CAN-10-4291","volume":"71","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma. Cancer Res. 71(19), 6106\u20136115 (2011).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47912-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47912-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47912-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:01:36Z","timestamp":1780660896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47912-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47912"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47912-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Helsinki Declaration and was approved by the Ethics Committee of Peking University Third Hospital (IRB00006761-M2019291). Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17444"}}